Core Insights - Primis Financial reported a fourth-quarter net interest income of approximately $31 million, an increase from $26 million year-over-year, with a net interest margin (NIM) of 3.28%, up from 2.90% a year earlier [2][4] - The company anticipates further margin improvements in 2026 due to an investment portfolio restructuring and the redemption of $27 million in subordinated debt, which could have increased NIM by about 11 basis points if fully implemented in Q4 [1][6] - Management projects run-rate earnings of roughly $8 million per quarter, equating to an 80-basis-point return on assets (ROA) on approximately $4 billion of average assets, with a target of achieving a 1% ROA in 2026 [3][19] Financial Performance - The fourth-quarter earnings per share (EPS) were reported at $1.20, driven by a substantial gain from a sale-leaseback transaction [4][6] - The company experienced a 10% annualized increase in gross loans held for investment from September 30 to December 31, with average earning assets rising 13% annualized in Q4 [6][8] - Non-interest-bearing deposits improved to 16% of total deposits by the end of 2025, up from 14% at the end of 2024, indicating a positive shift in deposit mix [7][9] Growth Drivers - Primis plans to scale its mortgage warehouse from approximately $175 million to around $500 million in 2026, with retail mortgage production targeted between $1.6 billion and $2 billion [5][11] - The mortgage warehouse business is expected to generate over 2% ROA, contributing positively to overall earnings as it scales [12][14] - Retail mortgage closed loans increased to approximately $1.2 billion in 2025, a 50% increase from 2024, with expectations for continued growth in 2026 [13][14] Expense Management - The company has controlled operating expenses, targeting a go-forward level of approximately $22 million, with expectations to maintain this as revenue grows [15][17] - Core expenses, excluding volatility from the mortgage and Panacea divisions, were approximately $28 million, with management aiming for a normalized level of $21 million [16][17] - The provision for credit losses was reported at $2.4 million, reflecting loan growth and specific reserving for impaired loans [18] Strategic Outlook - Management emphasized the importance of operational leverage and expects stronger performance in the second half of 2026, despite potential seasonality affecting the first quarter [19] - The company believes it has the capital and fundamentals necessary to pursue its goals, entering 2026 with positive momentum from recent restructuring efforts [19]

Beasley said revenue per hundredweight declined about 3% year-over-year, including and excluding fuel surcharges, primarily due to reduced shipment activity in the manufacturing vertical. He also cited higher costs tied to additional labor to support shipment growth, annual increases in contracted union labor rates, and higher equipment depreciation.In the Asset-Based segment, fourth-quarter revenue was $649 million and was described as flat on a per-day basis. The segment’s operating ratio was 96.2%, up 42 ...

Phoenix, AZ, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Cate & Chloe announced a Valentine’s Day gifting spotlight featuring hoop earrings and select jewelry styles currently listed on Walmart.com, including the Cate & Chloe Lauren 18k white gold plated twisted hoop earrings with Swarovski® crystals. Cate & Chloe Lauren 18k White Gold Plated Twisted Hoop Earrings The Lauren hoop earrings are listed in multiple color options on Walmart.com at a current price of $18.99, shown alongside a “was” price of $130.00 on the ...

NEW YORK, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Corcept Theraepeutics Incorporated (NASDAQ: CORT)?Did you lose money in your investment in Corcept Theraepeutics Incorporated?Do you want to discuss your rights? Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, is investigating whether Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) violated federal securities laws. If you own Corcept stock and would lik ...

I'm here right now with Brian Nichols, fresh off his Investor Day here in New York City and fresh off an earnings report that actually seemed to please a lot of investors for five quarters right now into your tenure as CEO of Starbucks. And you put together a couple of quarters of growth, something that the company hadn't seen in quite some time. Yeah, it was it was a great quarter for us.You know, the thing that was really exciting to see the growth was driven by transactions and also the fact that the ini ...

SoFi Technologies ( NASDAQ:SOFI ) reported impressive fourth-quarter 2025 earnings this morning, significantly exceeding Wall Street estimates and raising its earnings guidance for the coming year ahead of forecasts. ...

Key Takeaways Stride benefits from strong virtual K-12 and career learning demand, driving faster growth and margins.Strategic Education gains from employer-linked programs, but growth appears steadier and less dynamic.Valuation favors Stride with stronger ROE, rising estimates and a more attractive risk-reward profile.The shifting interests of students and parents toward online education alternatives, especially for career learning, have altered the perspective of the education market and the firms operati ...

Key Takeaways ACHR is highlighted as a key contender as demand grows for cleaner, faster urban air mobility solutions.ACHR is advancing FAA approval, adding NVIDIA-powered AI and expanding in Europe through a Serbia partnership.EHang secured autonomous eVTOL certification in China and completed a 22 km pilotless cross-strait flight.Rising demand for cleaner and more efficient travel is driving growth in the electric vertical takeoff and landing eVTOL industry, which is expected to play an important role in ...

Key Takeaways SMMT's FDA-accepted BLA seeks approval of ivonescimab plus chemo for NSCLC after third-generation EGFR-TKIs.SMMT faces Nov. 14, 2026, PDUFA date, with FDA planning mid- and late-cycle reviews and labeling talks.SMMT's BLA is backed by the phase III HARMONi data that met PFS, while OS missed but trended favorably.Summit Therapeutics (SMMT) announced that the FDA has accepted its biologics license application (BLA) seeking approval for ivonescimab plus chemotherapy in patients with EGFR-mutated, ...

Core Insights - Group 1 Automotive (GPI) reported a fourth-quarter 2025 adjusted earnings per share (EPS) of $8.49, a decrease of 15.3% year over year from $10.02, and missed the Zacks Consensus Estimate of $9.36 [1] - The company registered net sales of $5.58 billion, slightly up from $5.50 billion in the same quarter last year, but below the Zacks Consensus Estimate of $5.66 billion [1] GPI's Q4 Highlights - New vehicle retail sales fell 3.2% year over year to $2.77 billion, missing projections of $2.87 billion, with total retail new vehicles sold at 55,035 units, down 5% year over year [2] - The average selling price per new vehicle increased by 3.3% year over year to $52,776, while gross profit from new vehicle retail was $181.3 million, down 11.6% year over year [2] Used-Vehicle Sales Performance - Used-vehicle retail sales rose 5.2% year over year to $1.74 billion, surpassing forecasts of $1.67 billion, with total retail used vehicles sold at 55,474 units, a slight increase of 0.2% year over year [3] - The average selling price per used vehicle was $31,407, up 5.1% year over year, but gross profit from this segment decreased by 9.4% to $71.8 million [3] Wholesale and Parts & Service Performance - Used-vehicle wholesale sales increased by 11.4% year over year to $143.6 million, although it missed expectations of $149.4 million, with a gross loss of $2.7 million compared to a loss of $1.7 million in the previous year [4] - Parts and Service revenues rose 2.9% year over year to $700.2 million, with gross profit increasing by 6.3% to $394.2 million [4] Segment Performance - U.S. business segment revenues increased by 0.4% year over year to $4.25 billion, exceeding forecasts of $4.11 billion, but gross profit fell by 0.7% to $691.2 million, missing predictions of $707.9 million [5] - The U.K. business segment saw revenues jump 1.4% year over year to $1.33 billion, missing estimates of $1.52 billion, with gross profit slightly declining by 0.1% to $183.2 million [6] Financial Position - Selling, general and administrative expenses rose by 2.1% year over year to $627.3 million, while cash and cash equivalents decreased to $32.5 million from $34.4 million a year earlier [7] - Total debt increased to $3.70 billion as of December 31, 2025, up from $2.91 billion a year prior [7] Share Repurchase Activity - During the quarter, GPI repurchased 755,792 shares at an average price of $403.60 per share, totaling $305 million, with $378.7 million remaining on its authorized stock buyback program as of December 31, 2025 [8]